Small extracellular vesicles as biomarkers of response in recurrent/metastatic HNSCC patients treated with immunotherapy.
Dan P ZandbergChang-Sook HongAndrew SwartzRonan HsiehJennifer AndersonRobert L FerrisBrenda DiergaardeTheresa L Whiteside
Published in: BJC reports (2024)
Evaluation of the T cell-derived-CD3(+) and tumor-enriched CD3(-) plasma sEV subsets indicated their potential utility as biomarkers of response to immunotherapy.